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Vitamin D Physiology anD Function
Vitamin D is a fat-soluble vitamin which is only present in few 
foods, mainly in oil-rich fish such as salmon, mackerel, and herring. 
The main source (80-90%) of vitamin D is its synthesis in the skin 
upon absorption of UVB radiation by 7-dehydrocholesterol.1 It then 
undergoes hydroxylation in the liver to 25-hydroxyvitamin D; and 
then further hydroxylation to 1,25-hydroxyvitamin D by the enzyme 
1α-hydroxylase. 1,25-hydroxyvitamin D interacts with its vitamin D 
nuclear receptor, which is present in the small intestine, kidneys, and 
other tissues.1,2 1,25-hydroxyvitamin D promotes calcium absorption 
in the gastrointestinal tract and maintains adequate serum calcium 
and phosphate concentrations.3 1,25-hydroxyvitamin D also acts 
through its vitamin D receptor (VDR) in the osteoblast to stimulate 
the expression of receptor activator nuclear factor κB ligand. The 
latter interacts with the receptor activator of nuclear factor κB to 
stimulate immature monocytes to become mature osteoclasts, which 
dissolve the matrix and mobilize calcium and other minerals from the 
skeleton. It is thus important for bone growth and bone remodelling.4 
In the kidney, 1,25-hydroxyvitamin D stimulates calcium reabsorption 
from the glomerular filtrate.1,5 VDR is present in most cells and can 
regulate the transcription of over 200 genes. It has multiple biological 
actions, including modulation of cell growth, neuromuscular and 
immune functions, and reduction of inflammation.6 
Vitamin D DeFiciency
Vitamin D deficiency has been defined as serum 25-hydroxyvitamin 
D of less than 20ng/ml; while vitamin D insufficiency is defined as 
serum 25-hydroxyvitamin D of 21–29ng/ml.1 Vitamin D deficiency 
is common; its prevalence in adults in Europe ranges from 34% 
to 67%.7 The major cause of vitamin D deficiency is inadequate 
exposure to sunlight.8 Vitamin D synthesis in the skin is reduced 
by more than 95% by using sunscreen with a sun protection factor 
of 30.9 People with a naturally dark skin tone are more prone to 
vitamin D deficiency, since they require at least three to five times 
longer sun exposure to make the same amount of vitamin D as a 
person with a white skin tone.10,11 Other risk factors include obesity, 
fat malabsorption, and medications including anticonvulsants and 
anti-retroviral therapy.12,13 
consequences oF Vitamin D DeFiciency
Vitamin D deficiency results in abnormalities in calcium, 
phosphorus, and bone metabolism. Vitamin D deficiency causes 
a decrease in the intestinal calcium and phosphorus absorption, 
resulting in an increase in parathyroid hormone levels.1 Secondary 
hyperparathyroidism maintains normal serum calcium levels by 
promoting calcium absorption from bone and increasing phosphorus 
excretion by the kidneys. The increase in osteoclastic activity creates 
local foci of bone weakness and a generalized decrease in bone 
mineral density, resulting in osteopaenia and osteoporosis. The 
increased phosphorus excretion results in lower serum phosphorus 
levels, causing a mineralization defect in the skeleton.14 In young 
children this results in a variety of skeletal deformities classically 
known as rickets.15 In adults, this mineralization defect known as 
an osteomalacia, often goes undetected. It causes a decrease in bone 
mineral density and is associated with bone and muscles aches.16 
Vitamin D deficiency also causes muscle weakness; affected children 
abstract
Vitamin D deficiency has a high prevalence due to inadequate exposure to sunlight and its limited presence in foods. Vitamin D 
deficiency has well-known consequences on the musculoskeletal system, namely osteoporosis and frequent falls in the elderly, in view 
of its effect on calcium absorption. The discovery of the vitamin D receptor in many cells and its ability to regulate the transcription of 
over 200 genes, has created interest with regards to the role of vitamin D in the modulation of cell growth, inflammation and immune 
functions. Guidelines recommend screening individuals at risk of vitamin D deficiency, and supplementing when necessary.
KeyworDs
Vitamin D, osteomalacia, autoimmune disease, malignancy, cardiovascular disease
Vitamin D
Its role In the 
mUscUloskeletal 
system and Beyond rosalie magro & anDrew borg 
6 Volume 16, 2017  Issue 05

Knee, lumbar, neck, elbow, abdominal, hernia, 
ankle, wrist, and shoulder supports and braces.
115 Birkirkara Road, San Gwann, SGN4190, Malta
21314333
customercare@jamescotrading.com
have difficulty standing and walking, whereas the elderly have more 
frequent falls and higher fracture risk.15,17,18 
The discovery of the presence of VDR and the enzyme 
1α-hydroxylase in a large number of different cells has created interest 
on the importance of VDR-directed gene expression on the function 
of many tissues. A large number of studies have explored the effects 
of vitamin D beyond its well-known effects on the musculoskeletal 
system. Observational studies have described associations between 
low circulating levels of 25-hydroxyvitamin D and a large number of 
diseases, including cardiovascular diseases, malignancies, diabetes, 
obesity and autoimmune diseases.19-22 Moreover, polymorphisms of 
VDR have been associated with several autoimmune diseases, such as 
systemic lupus erythematosus, type 1 diabetes, autoimmune thyroid 
disease, and with a number of malignancies.23-29
Diagnosis oF Vitamin D DeFiciency
Guidelines recommend screening for vitamin D deficiency in patients 
at risk, such as patients with osteoporosis, chronic kidney disease, 
liver failure, malabsorption, patients on anticonvulsants, obese 
individuals and elderly patients suffering from frequent falls.30 Serum 
25-hydroxyvitamin D is the major circulating form of vitamin D, and it 
is recommended to assess its level in order to evaluate vitamin D status.
treatment oF Vitamin D DeFiciency anD insuFFiciency
The guidelines recommend that adults who are vitamin D 
deficient are treated with 50,000 IU of vitamin D2 or vitamin D3 
once a week for 8 weeks or its equivalent of 6000 IU of vitamin 
D2 or vitamin D3 daily for 8 weeks to achieve a blood level of 
25-hydroxyvitamin D above 30ng/ml. This is then followed by 
maintenance therapy of 1500–2000 IU daily.30 To treat vitamin 
D deficiency in obese patients, patients with malabsorption 
syndromes, and patients on medications affecting vitamin D 
metabolism, such as anti-convulsants, the guidelines recommend 
a loading and maintenance dose that is two to three times higher. 
They recommend a loading dose of at least 6000–10,000 IU daily, 
followed by maintenance therapy of at least 3000–6000 IU daily.
conclusion
Adequate vitamin D is vital for maintaining good bone and muscle 
health. Observational studies suggest a role of vitamin D in the 
development of autoimmune diseases, malignancy and cardiovascular 
disease. Large randomised controlled studies are required to define 
the role of vitamin D in these conditions. Screening for vitamin 
D deficiency in individuals at risk is recommended, followed by 
supplementation in vitamin D deficiency and insufficiency.  
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